Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LAL-AR-N-2005: Study Treatment for Children High Risk Acute Lymphoblastic Leukemia

NCT00526409 is registered in ClinicalTrials.gov with PETHEMA Foundation as lead sponsor.

NCT NCT00526409
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00526409 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LAL-AR-N-2005: Study Treatment for Children High Risk Acute Lymphoblastic Leukemia
Lead sponsor
PETHEMA Foundation
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2005
Completion date
October 31, 2014
Enrollment
40 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia